Computer Aided Simulation Analysis (Casa) in Order to Test Cost-Effectiveness of Drugs Using the Example of Ceftriaxone (RocephinR)

It is well known that the methods currently being used in successful drug development are very expensive, involving a large number of carefully monitored clinical trials and provide the results only after a long period of time. Even when a standardized registration procedure is followed, however, it does not necessarily guarantee that the medication will become available on the market. This may be due in part to the pharmaceutical industry which, in addition to fulfilling its usual requirements in establishing sufficient proof of the efficacy and safety of a new drug to the regulatory authorities as well as to the health insurances, also often has to substantiate the drugs economic efficiency.